PDT Partners, LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1564702 New York, NY

Position in SUPN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,202,655

-$2,760,572 QoQ

Shares Held

25,858

-66.3% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#128

of 331 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PDT Partners, LLC holds $16,723,036 across 8 Drug Manufacturers - Specialty & Generic names. SUPN ranks #5 (7.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	117,378	$4,816,019
2	ANIP	Ani Pharmaceuticals Inc	45,442	$3,761,688
3	PCRX	Pacira BioSciences, Inc.	132,368	$3,358,176
4	KNSA	Kiniksa Pharmaceuticals International, plc	40,567	$2,594,259
5	SUPN	Supernus Pharmaceuticals, Inc. This page	25,858	$1,202,655
6	ETON	Eton Pharmaceuticals, Inc.	14,891	$539,054
7	BCRX	Biocryst Pharmaceuticals Inc	24,489	$244,890
8	BHC	Bausch Health Companies Inc.	41,845	$206,295

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,202,655	25,858	-66.3%	Shares	Sole	2026-08-14
2026-03-31	$3,963,227	76,673	0.0%	Shares	Sole	2026-05-15
2025-12-31	$3,810,648	76,673	-13.1%	Shares	Sole	2026-02-17
2025-09-30	$4,218,566	88,273	-6.4%	Shares	Sole	2025-11-17
2025-06-30	$2,972,556	94,307	+152.3%	Shares	Sole	2025-08-14
2025-03-31	$1,224,227	37,381	-32.0%	Shares	Sole	2025-05-15
2024-12-31	$1,989,089	55,008	+48.2%	Shares	Sole	2025-02-14
2024-09-30	$1,157,089	37,110	-24.3%	Shares	Sole	2024-11-14
2024-03-31	$1,672,413	49,030	+9.8%	Shares	Sole	2024-05-15
2022-12-31	$1,592,522	44,646	+0.0%	Shares	Sole	2023-02-14
2022-09-30	$1,510,860	44,634	-32.3%	Shares	Sole	2022-11-14
2022-06-30	$1,907,071	65,943	+131.0%	Shares	Sole	2022-08-15
2020-03-31	$513,614	28,550	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.